Abstract
Response and Outcomes of Third-Line Tyrosine Kinase Inhibitor Therapy on Patients with Chronic Phase Chronic Myeloid Leukemia
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
https://doi.org/10.1182/blood.v130.suppl_1.2882.2882
Copy DOIJournal: Blood | Publication Date: Jun 25, 2021 |
Response and Outcomes of Third-Line Tyrosine Kinase Inhibitor Therapy on Patients with Chronic Phase Chronic Myeloid Leukemia
Join us for a 30 min session where you can share your feedback and ask us any queries you have